India is facing yet another challenge in terms of fighting Covid pandemic. The second phase has brought forward the challenge of COVID vaccination drive that has to be conducted in the country in order to bring some stability on ground. RDIF and Panacea Biotec have launched the production of Sputnik V in India. India's Panacea Biotec is said to produce 100 million doses of Sputnik V per year.

► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1

► More Videos @ ETTV - http://economictimes.indiatimes.com/TV

► http://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp

Follow ET on:

► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes